Keyphrases
Catalonia
100%
Spain
82%
COVID-19
70%
Primary Immunodeficiency
69%
Pediatric
49%
Newborn Screening
48%
Pediatric Patients
47%
AIDS/HIV
38%
Severe Combined Immunodeficiency
37%
Inflammation
34%
Barcelona
32%
T-cell Receptor Excision Circles
31%
Polymerase Chain Reaction
27%
T Cells
26%
Cytomegalovirus Infection
25%
Europe
24%
Multisystem Inflammatory Syndrome in children (MIS-C)
23%
Hospitalization
23%
Cytomegalovirus
23%
Clinical Outcomes
21%
HIV-infected children
21%
Odds Ratio
20%
Confidence Interval
20%
Immunodeficiency
20%
Virus
19%
Zika Virus
19%
Array Comparative Genomic Hybridization (aCGH)
18%
Dried Blood Spots
18%
Infected children
17%
Hebron
17%
Antiretroviral
16%
Quantitative PCR
16%
Zika Virus Infection
16%
At Birth
16%
Pediatric Population
15%
Metabolic Syndrome
15%
Hyperlactatemia
15%
Complement Factors
15%
Neonatal Screening
15%
Human Immunodeficiency Virus Type 1 (HIV-1)
15%
Autoinflammatory
15%
Imported Diseases
15%
Acute Lower Respiratory Tract Infection
15%
Universal Newborn Screening
15%
Off-label Use
15%
Surgical Wound Infection
15%
Clinical Impact
15%
Type I Interferon
15%
Tertiary Hospital
15%
Type I IFN
15%
Medicine and Dentistry
Human Immunodeficiency Virus
83%
Pediatrics
70%
Infection
53%
Pediatrics Patient
46%
Newborn Screening
40%
Diseases
38%
COVID-19
32%
Adolescence
29%
Severe Acute Respiratory Syndrome Coronavirus 2
28%
Polymerase Chain Reaction
27%
Severe Combined Immunodeficiency
27%
Immune Deficiency
26%
Zika Virus
23%
Serositis
23%
Dried Blood Spot
22%
Cytomegalovirus
22%
T Lymphocyte Receptor
21%
Retrospective Study
20%
Screening
19%
Intensive Care
18%
Congenital Cytomegalovirus Infection
16%
Odds Ratio
16%
Off-Label Use
15%
Humoral Immune Deficiency
15%
Metabolic Syndrome
15%
Human Cytomegalovirus
15%
Zika Fever
15%
Heart Surgery
15%
Surgical Infection
15%
Meningitis
15%
Bronchiolitis
13%
Real Time Polymerase Chain Reaction
13%
Neonatal Infant
13%
Cytomegalovirus Infection
13%
Clinical Trial
13%
Early Diagnosis
12%
T Lymphocyte
11%
Human Respiratory Syncytial Virus
11%
Pneumococcal Infection
11%
Immigrant
11%
Streptococcus Pneumonia
11%
Prevalence
11%
Antiinfective Agent
11%
Human Immunodeficiency Virus Infection
9%
Hematology
9%
Infection Control
9%
Epidemiological Surveillance
9%
Intensive Care Unit
9%
Bacterial Infection
9%
Pneumococcal Pneumonia
9%
Immunology and Microbiology
Human Immunodeficiency Virus
69%
Immunodeficiency
58%
COVID-19
38%
T Cell
32%
Adolescence
30%
T-Cell Receptor Excision Circles
29%
Prevalence
28%
Severe Acute Respiratory Syndrome Coronavirus 2
24%
Newborn Screening
23%
Severe Combined Immunodeficiency
18%
Array Comparative Genomic Hybridization
17%
B Cell
16%
Chromosome 4
15%
DNA Methylation
15%
Human Immunodeficiency Virus 1
15%
Autoantibodies
15%
Interferon Type I
15%
Screening
15%
Immunoglobulin A
15%
Common Variable Immunodeficiency
15%
CD4
13%
Primary Immunodeficiency
12%
Exon
12%
Cytotoxic T-Cell
12%
Humoral Immune Deficiency
12%
TLR3
11%
Autoinflammatory Syndromes
11%
Regulatory T Cell
11%
Haploinsufficiency
11%
Dynamics
11%
Immunopathology
10%
Cell Population
10%
Whole Exome Sequencing
10%
Influenza
9%
Human Immunodeficiency Virus Infection
9%
Kawasaki Disease
9%
Autosomal Recessive Inheritance
9%
Reference Value
9%
Chronic Granulomatous Disease
9%
Autoimmunity
8%
Viral Load
8%
Ataxia Telangiectasia
8%
Complement System
7%
Cytokine
7%
Autoimmune Lymphoproliferative Syndrome
7%
Uniparental Disomy
7%
Kidney Function
7%
Lower Respiratory Tract
7%
Pneumocystis Jiroveci
7%
Pathogenicity
7%
